Skip to content

Virtual Reality Intervention for Speech Anxiety

The Influence of Mood on Response to Virtual Reality-Based Exposure for Public Speaking Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06086756
Enrollment
48
Registered
2023-10-17
Start date
2023-11-01
Completion date
2023-12-05
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Public Speaking, Speech Anxiety

Brief summary

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.

Detailed description

The goal of this clinical trial is to compare outcomes of VR exposure therapy for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to determine whether mood state prior to engaging in a brief VR exposure therapy session for public speaking anxiety impacts treatment outcomes. The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR based exposure therapy. Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later. Researchers will compare participants given a positive mood induction to participants given a negative mood induction to see if public speaking anxiety outcomes differ.

Interventions

BEHAVIORALExposure intervention plus positive mood induction

Positive mood induction followed by a brief VR exposure session for public speaking anxiety.

BEHAVIORALExposure intervention plus negative mood induction

Negative mood induction followed by a brief VR exposure session for public speaking anxiety.

Sponsors

Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Self-report of 18 years of age or older * Current student at Boston University * Ability to read English to provide informed consent * Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet). * For Phase 2: speech anxiety scale score of ≥ 14 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Exclusion criteria

* Previous participation (i.e., no participant may take the survey more than once).

Design outcomes

Primary

MeasureTime frameDescription
Public Speaking AnxietyComparison of pre-exposure scores to scores from post-treatment, approximately 2 week post-screenAssessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Secondary

MeasureTime frameDescription
ValenceComparison of pre-exposure scores to scores from follow up survey, 1 week post-exposureSelf-report measure of how participant feels about having to give a speech
Social PhobiaComparison of pre-exposure scores to scores from follow up survey, 1 week post-exposureAssessed using the social phobia inventory (SPIN)
Public Speaking AnxietyComparison of pre-exposure scores to scores from follow up survey, 1 week post-exposureAssessed using the PRCA-PS

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026